Integrated Drug Discovery, Drug Development and Manufacturing
Dalton Pharma Services is a leading cGMP contract service provider of integrated drug discovery, development and manufacturing services to the pharmaceutical and biotechnology industries. We are FDA registered and Health Canada approved, and bring over
30 years of experience to every project. We deliver fully integrated solutions with an emphasis on speed, flexibility and quality. We are experts in Custom Synthesis, cGMP API Manufacturing,
Formulation Development, API Process Development, Sterile Filling Services and Accelerated Stability Testing.
We understand your project needs and will deliver:
♦ Highest Quality
♦ Shorter Timelines
♦ Minimized Cost
♦ Regulatory Compliance
♦ Keeping you Informed
News
As a part of a 10 million dollar facility and capital expansion, Dalton Pharma Services, a leading North American contract research, development & manufacturing organization has invested in a fully automated Sterile Liquid Filling System that will
become operational in Q1 of 2019.
Arch Biopartners announces it has engaged Dalton Pharma to perform the good manufacturing practice (GMP) campaign for Metablok, the Company's drug candidate for preventing acute kidney injury.
Dalton expands its elemental analysis testing capabilities with the addition of an ICP-MS System.
Canada's leading pharmaceutical CMO, Dalton Pharma Services, is recognized as a Best Workplace™ in Canada, 2018.
Pharmaceutical Outsourcing conducts an interview with Peter Pekos, President & CEO, Dalton Pharma Services.
Dalton Pharma Services today announced the signing of a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharmaceutical company based in Gaithersburg, Maryland, USA.
